CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation. [electronic resource]
Producer: 20040323Description: 1509-13 p. digitalISSN:- 1042-8194
- Acute Disease
- Adolescent
- Adult
- Antigens, CD34 -- analysis
- Cyclophosphamide -- administration & dosage
- Cyclosporine -- therapeutic use
- Female
- Graft Survival
- Graft vs Host Disease -- etiology
- Hematopoietic Stem Cells -- immunology
- Humans
- Immunomagnetic Separation
- Immunophenotyping
- Immunosuppressive Agents -- therapeutic use
- Leucovorin -- therapeutic use
- Leukemia, Myeloid -- therapy
- Lymphocyte Depletion -- methods
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Peripheral Blood Stem Cell Transplantation -- adverse effects
- T-Lymphocytes, Cytotoxic -- immunology
- Transplantation Conditioning
- Transplantation, Homologous -- adverse effects
- Whole-Body Irradiation
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.